Mean (range) T-score difference from baseline to EOS and baseline to EOT at lumbar spine, total hip, and femoral neck, respectively (efficacy group; 47 patients)
. | ΔTEOS (ALN) . | ΔTEOS (placebo) . | Difference . | P . |
---|---|---|---|---|
EOS (12 mo) | ||||
Lumbar spine* | 0.15 (−0.70 to 0.90) | −0.12 (−0.80 to 0.80) | 0.28 (0.04−0.51) | .023 |
Total hip† | −0.05 (−0.70 to 0.30) | −0.10 (−0.40 to 0.30) | 0.05 | .175 |
Femoral neck* | −0.07 (−0.60 to 0.40) | −0.10 (−0.50 to 0.30) | 0.03 (−0.11 to 0.18) | .624 |
EOT (4 to 6 mo) | ||||
Lumbar spine* | 0.01 (−0.60 to 0.70) | −0.00 (−0.60 to 1.00) | 0.01 (−0.19 to 0.22) | .896 |
Total hip‡ | −0.05 (−0.70 to 0.50) | −0.05 (−0.30 to 0.20) | 0.00 (−0.12 to 0.12) | 1.000 |
Femoral neck† | −0.11 (−0.40 to 0.40) | −0.02 (−0.40 to 0.30) | −0.10 | .175 |
. | ΔTEOS (ALN) . | ΔTEOS (placebo) . | Difference . | P . |
---|---|---|---|---|
EOS (12 mo) | ||||
Lumbar spine* | 0.15 (−0.70 to 0.90) | −0.12 (−0.80 to 0.80) | 0.28 (0.04−0.51) | .023 |
Total hip† | −0.05 (−0.70 to 0.30) | −0.10 (−0.40 to 0.30) | 0.05 | .175 |
Femoral neck* | −0.07 (−0.60 to 0.40) | −0.10 (−0.50 to 0.30) | 0.03 (−0.11 to 0.18) | .624 |
EOT (4 to 6 mo) | ||||
Lumbar spine* | 0.01 (−0.60 to 0.70) | −0.00 (−0.60 to 1.00) | 0.01 (−0.19 to 0.22) | .896 |
Total hip‡ | −0.05 (−0.70 to 0.50) | −0.05 (−0.30 to 0.20) | 0.00 (−0.12 to 0.12) | 1.000 |
Femoral neck† | −0.11 (−0.40 to 0.40) | −0.02 (−0.40 to 0.30) | −0.10 | .175 |